TGFBR2 and colorectal carcinoma: To investigate the efficacy of our platform in a translational setting in which TAs have not been previously identified, we employed AKTPF CRC cells derived from APCD716; KrasG12D; Tgfbr2–/–; Trp53R270H; Fbxw7–/– mice15,33.